Composition of Certain Financial Statement Captions (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015		Dec. 31, 2014
Accounts receivable, net
Accounts receivable	$ 20,755		$ 21,875
Less: allowance for doubtful accounts	(1,691)		(1,906)
Accounts receivable, net	19,064	[1]	19,969	[1]
Inventories, net
Finished products	14,349		12,116
Work in-process	891		1,011
Raw materials	3,638		4,116
Less: inventory reserve	(554)		(639)
Inventory, net	18,324	[1]	16,604	[1]
Prepaid expenses and other current assets
Prepaid supplies	1,319		1,123
Prepaid insurance	1,041		968
Other receivables	733		669
Taxes recoverable	1,968		2,417
Other	3,384		4,212
Prepaid expenses and other current assets	8,445	[1]	9,389	[1]
Intangible assets, net:
Less: accumulated amortization	(35,928)		(33,931)
Intangible assets, net	59,432	[1]	62,649	[1]
Accrued expenses:
Taxes payable	3,008		77
Deferred revenue	74,789		4,185
Clinical trials	9,620		8,643
Professional fees	1,624		1,860
Employee benefits	6,495		4,127
Contingent consideration	52,838		27,352
Other	10,389		14,668
Accrued expenses	158,763	[1]	60,912	[1]
Other long-term liabilities:
Mortgages and other debts payable	2,185		2,434
Deferred tax liabilities	166,922		167,153
Deferred revenue	214,017		2,526
Other	3,368		1,030
Other long-term liabilities	410,165	[1]	217,358	[1]
OPKO Renal
Other long-term liabilities:
Contingent consideration	18,841		36,529
OPKO Health Europe
Other long-term liabilities:
Contingent consideration	0		254
Mortgages and other debts payable	2,185		2,435
OPKO Diagnostics
Other long-term liabilities:
Contingent consideration	4,375		6,992
CURNA
Other long-term liabilities:
Contingent consideration	457		440
Technologies
Intangible assets, net:
Intangible assets	52,167		52,508
Customer relationships
Intangible assets, net:
Intangible assets	21,943		22,108
Product registrations
Intangible assets, net:
Intangible assets	8,224		8,763
Trade names
Intangible assets, net:
Intangible assets	3,417		3,483
Covenants not to compete
Intangible assets, net:
Intangible assets	8,618		8,639
Other
Intangible assets, net:
Intangible assets	$ 991		$ 1,079

[1] As of March 31, 2015 and December 31, 2014, total assets include $7.1 million and $7.6 million, respectively, and total liabilities include $12.1 million and $12.1 million, respectively, related to SciVac Ltd (“SciVac”), previously known as SciGen (I.L.) Ltd, a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and SciVac’s consolidated liabilities have no recourse against us. Refer to Note 5.